The French High Authority for Health (HAS) develops clinical guidelines and recommendations whose objective is to guarantee the quality and safety of care delivery within the French setting. In the second quarter of 2019, clinical guidelines/recommendations/reports have been developed for the following 16 topics:
- Management of common bacterial skin infections
- Management of the patients with lower back pain
- The national protocol for diagnosis and care pathway of patients with Aniridia
- The national protocol for diagnosis and care pathway of pediatric patients with multiple sclerosis
- Conciliation of drug treatments in oncology
- Medico-economic evaluation of biological progestins in the management of rheumatoid arthritis
- Management of adult patients with hepatitis C
- Antibiotics of enterobacterial and pseudomonas aeruginosa infections in adults: a place of carbapenems and their alternatives
- Quality of life at the workplace
- Evaluation of social clusters quality of life at work in health and medico-social establishments
- Rehabilitation pathways after the initial phase of stroke
- The national protocol for diagnosis and care pathway of patients with Crohn’s disease (update)
- Type V Glycogenosis, McArdle’s Disease
- Infant myoclonic epilepsy
- Teleimaging
- Teleconsultation and teleexpertise
- Vaccine recommendation against invasive meningococcal disease B: Place of the Trumenba® vaccine-Roadmap
- Systemic necrotic vasculitis (periarteritis nodosa and vasculitis associated with ANCA)
See the full news in French here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.